FDA 510(k) FDA class 2 Substantially Equivalent 🇬🇧 United Kingdom

BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16 (Concentrated Liquid Antibody Format).

K Number: K193393 · Decision Mar 6, 2020
Classifications
1
FEI Numbers
13
Registration Numbers
13
Same Product Code
12
Applicant Total
3
Review Days
91

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16 (Concentrated Liquid Antibody Format).
K Number
K193393
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
864.1860
Medical Specialty
Hematology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Leica Biosystems Newcastle, Ltd.
Date Received
December 6, 2019
Decision Date
March 6, 2020
Product Code
MXZ
Advisory Committee
Hematology
Review Advisory Committee
PA
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MXZ Immunohistochemistry Assay, Antibody, Progesterone Receptor

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (MXZ), ordered by most recent decision date.

View all

Other Clearances by Leica Biosystems Newcastle, Ltd.

K Number Device Name
K213348 BOND MMR Antibody Panel
K122556 VISION BIOSYSTEMS ESTROGEN RECEPTOR CLONE 6F11 (ER 6F11)